AzTrials
AzTrials

Childhood or Juvenile Absence EpilepsyAbsence SLINCT03676543

Mutual Interactions Between Absence Epilepsy Seizures and the Integration of Sensory Stimuli

A study testing Timed repetitive sensory stimulation in people with Childhood or Juvenile Absence Epilepsy, run by Fondation Ophtalmologique Adolphe de Rothschild at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Epileptic seizures arise from neuronal defects that often alter the capacity of the brain to process sensory information. During absence seizures, a frequent epileptic syndrome in children, the normal conscious and perceptual processes are temporarily interrupted. Read more about this study

Who is it for?
Ages 2 to 21 years
Conditions the study is for
Childhood or Juvenile Absence Epilepsy
What is being tested?
Timed repetitive sensory stimulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1 participants
Where
1 siteFrance
Study dates
7 Jun 2018to 29 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 21 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Age 2-20 years
  • childhood or juvenile absence epilepsy defined by International Ligue Against Epilepsy (ILAE)
  • Electroencephalogram (EEG) indicated for clinical follow-up
  • Non inclusion criteria:
  • Visual deficit
  • Abnormal Magnetic Resonance Imaging (MRI)
  • Medical history of photosensitive epileptic seizures

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Fondation OPH A. de Rothschild

    Paris

Other trials in France

About this study

Epileptic seizures arise from neuronal defects that often alter the capacity of the brain to process sensory information. During absence seizures, a frequent epileptic syndrome in children, the normal conscious and perceptual processes are temporarily interrupted. This is the result of abnormal synchronized neural activities in the thalamo-cortical loops, leading to bilateral spike-and-wave discharges (SWDs) in the cortical electroencephalograms (EEGs). The brain mechanisms underlying the lack of sensory experience during absence seizures are disputed. Based on preliminary data, the investigators hypothesize that the alternation of 'spike' and 'wave' patterns during seizure could cause a time-to-time inconstancy in cortical responsiveness, preventing conscious perception. Using a real-time closed-loop stimulation system, the investigators will research how the S- and W-patterns specifically alter the sensory-evoked responses in the EEG. During a standard EEG, visual stimulations will be applied between and during absence seizures to test the hypothesis that repeated sensory stimuli, applied with an appropriate timing relative to the seizure-related oscillatory cycle, could negatively interfere with the regenerative network mechanisms involved in the occurrence of SWDs. The completion of this project should permit to unveil a new neuronal mechanism supporting the lack of conscious experience during absences and pave the way for new clinical non-invasive strategies to interrupt ongoing seizure activity.

Being tested
Timed repetitive sensory stimulation
Medical subject headings
Epilepsy, Absence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Timed repetitive sensory stimulationProcedure or surgery

    Timed repetitive sensory stimulation (TRSS) will be applied at the onset or during seizures

Study groups in NCT03676543
Study groupRoleWhat they receive
Timed repetitive sensory stimulationExperimentalTimed repetitive sensory stimulation (TRSS) will be applied at the onset or during seizures
Receives: Procedure: Timed repetitive sensory stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modification of the frequency within the peak-wave complexes according to the repeated sensory stimulation and the duration of the absence epilespy crisis

    Modification of the frequency within the peak-wave complexes according to the repeated sensory stimulation and the duration of the absence epilespy crisis

    Measured: 1 hour

  2. Modification of the duration of the absence epilespy crisis according to the repeated sensory stimulation

    Modification of the duration of the absence epilespy crisis according to the repeated sensory stimulation

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2018
  2. Study start7 Jun 2018
  3. Primary completion29 Aug 2022
  4. Study completion29 Aug 2022

Why it stopped: This is the end of the inclusion period and only 1 patient has been recruited.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03676543
Sponsor's protocol ID
MCX_2017_28
Acronym
Absence SLI
Status last verified
Sep 2022
First submitted
31 Jul 2018
Last updated
21 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Timed repetitive sensory stimulation in people with Childhood or Juvenile Absence Epilepsy, run by Fondation Ophtalmologique Adolphe de Rothschild at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 21 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: This is the end of the inclusion period and only 1 patient has been recruited.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modification of the frequency within the peak-wave complexes according to the repeated sensory stimulation and the duration of the absence epilespy crisis (time frame: 1 hour). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2022; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in